Aarti Drugs Ltd. reported consolidated revenue of ₹6.02 billion for the December quarter, with net profit rising to ₹405.4 million. The board also declared an interim dividend of ₹2 per share. The results highlight steady growth, operational resilience, and shareholder returns in a competitive pharmaceutical landscape.
Show moreStay Ahead – Explore Now! Power Grid Raises FY26 Capex Guidance to ₹320 Billion, Signaling Strong Infrastructure Push
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
